Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

• Status: Enrolling by invitation
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate and compare the effect of immunoadsorption effect of A-V ECMO on course of sepsis weaning from inotropes, weaning from the ventilator, duration of ICU stays and effect on mortality rate in patients with septic shock and respiratory failure due to ARDS followed severe lung contusion.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mohamed Gaber Allam
• Collaborator: King Abdul Aziz Specialist Hospital
• Treatments: Meropenem

Criteria

Inclusion Criteria:

• Those who had an age between 18-65 years old

• patients ventilated for more than 10 days

• with conscious level more than 8/15 on Glasgow Coma Scale

Exclusion Criteria:

pediatric patients below 18 years of age